Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(-1.23%)
USD 46.75
(-1.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 576.41 Million EUR | 242.17% |
| 2022 | 459.82 Million USD | -10.71% |
| 2021 | 514.98 Million USD | 16.2% |
| 2020 | 443.17 Million USD | -9.52% |
| 2019 | 489.78 Million USD | -57.03% |
| 2018 | 1.13 Billion EUR | 2.78% |
| 2017 | 1.1 Billion EUR | 4.96% |
| 2016 | 1.05 Billion EUR | 2.57% |
| 2015 | 1.03 Billion EUR | 6.86% |
| 2014 | 964.04 Million EUR | 6.24% |
| 2013 | 907.43 Million EUR | 6.18% |
| 2012 | 854.6 Million EUR | 4.29% |
| 2011 | 819.46 Million EUR | 5.5% |
| 2010 | 776.77 Million EUR | 4.78% |
| 2009 | 741.33 Million EUR | 14.36% |
| 2008 | 648.23 Million EUR | 9.54% |
| 2007 | 591.79 Million EUR | 5.75% |
| 2006 | 559.61 Million EUR | 9.23% |
| 2005 | 512.31 Million EUR | 15.63% |
| 2004 | 443.06 Million EUR | -17.48% |
| 2003 | 536.93 Million EUR | 25.66% |
| 2002 | 427.28 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 428.82 Million EUR | 9.73% |
| 2024 Q2 | 436.31 Million EUR | 1.75% |
| 2023 FY | 1.57 Billion EUR | 242.17% |
| 2023 Q3 | 154.07 Million EUR | 15.9% |
| 2023 Q4 | 390.81 Million EUR | 153.65% |
| 2023 Q1 | 130.3 Million USD | 41.14% |
| 2023 Q2 | 132.94 Million USD | 2.02% |
| 2022 Q4 | 92.31 Million USD | -26.18% |
| 2022 FY | 459.82 Million USD | -10.71% |
| 2022 Q1 | 336.29 Million EUR | 1.0% |
| 2022 Q2 | 343.14 Million EUR | 2.04% |
| 2022 Q3 | 125.05 Million USD | -63.56% |
| 2021 Q2 | 329.05 Million EUR | 5.13% |
| 2021 Q1 | 313 Million EUR | -0.96% |
| 2021 Q3 | 362.49 Million EUR | 10.16% |
| 2021 Q4 | 332.95 Million EUR | -8.15% |
| 2021 FY | 514.98 Million USD | 16.2% |
| 2020 Q4 | 316.03 Million EUR | -6.81% |
| 2020 FY | 443.17 Million USD | -9.52% |
| 2020 Q3 | 339.13 Million EUR | 56.48% |
| 2020 Q2 | 216.72 Million EUR | -21.15% |
| 2020 Q1 | 274.85 Million EUR | -69.42% |
| 2019 Q4 | 898.74 Million EUR | 184.1% |
| 2019 FY | 489.78 Million USD | -57.03% |
| 2019 Q2 | 301.66 Million EUR | -1.51% |
| 2019 Q1 | 306.28 Million EUR | 9.2% |
| 2019 Q3 | 316.34 Million EUR | 4.87% |
| 2018 Q2 | 283.23 Million EUR | 0.64% |
| 2018 Q4 | 280.46 Million EUR | -4.85% |
| 2018 FY | 1.13 Billion EUR | 2.78% |
| 2018 Q1 | 281.42 Million EUR | 7.3% |
| 2018 Q3 | 294.77 Million EUR | 4.08% |
| 2017 Q3 | 286.1 Million EUR | 1.39% |
| 2017 FY | 1.1 Billion EUR | 4.96% |
| 2017 Q1 | 278.56 Million EUR | 7.78% |
| 2017 Q2 | 282.17 Million EUR | 1.3% |
| 2017 Q4 | 262.28 Million EUR | -8.33% |
| 2016 FY | 1.05 Billion EUR | 2.57% |
| 2016 Q3 | 270.33 Million EUR | 0.42% |
| 2016 Q2 | 269.21 Million EUR | 4.08% |
| 2016 Q4 | 258.46 Million EUR | -4.39% |
| 2016 Q1 | 258.66 Million EUR | 6.75% |
| 2015 Q3 | 269.93 Million EUR | 4.78% |
| 2015 FY | 1.03 Billion EUR | 6.86% |
| 2015 Q4 | 242.29 Million EUR | -10.24% |
| 2015 Q1 | 260.33 Million EUR | 13.88% |
| 2015 Q2 | 257.61 Million EUR | -1.04% |
| 2014 Q4 | 228.6 Million EUR | -7.61% |
| 2014 Q3 | 247.44 Million EUR | 3.59% |
| 2014 Q1 | 249.14 Million EUR | 11.7% |
| 2014 Q2 | 238.85 Million EUR | -4.13% |
| 2014 FY | 964.04 Million EUR | 6.24% |
| 2013 FY | 907.43 Million EUR | 6.18% |
| 2013 Q3 | 232.44 Million EUR | 2.16% |
| 2013 Q2 | 227.53 Million EUR | 1.38% |
| 2013 Q1 | 224.42 Million EUR | 8.27% |
| 2013 Q4 | 223.04 Million EUR | -4.04% |
| 2012 Q3 | 219.27 Million EUR | 3.74% |
| 2012 Q1 | 216.67 Million EUR | 8.47% |
| 2012 Q4 | 207.28 Million EUR | -5.47% |
| 2012 Q2 | 211.37 Million EUR | -2.45% |
| 2012 FY | 854.6 Million EUR | 4.29% |
| 2011 FY | 819.46 Million EUR | 5.5% |
| 2011 Q4 | 199.74 Million EUR | -5.18% |
| 2011 Q3 | 210.67 Million EUR | 3.98% |
| 2011 Q2 | 202.61 Million EUR | -1.85% |
| 2011 Q1 | 206.43 Million EUR | -13.6% |
| 2010 Q2 | 193.2 Million EUR | 1.49% |
| 2010 Q4 | 238.92 Million EUR | 20.14% |
| 2010 Q3 | 198.87 Million EUR | 2.93% |
| 2010 FY | 776.77 Million EUR | 4.78% |
| 2010 Q1 | 190.36 Million EUR | 8.15% |
| 2009 Q2 | 169.92 Million EUR | 3.32% |
| 2009 Q3 | 174.2 Million EUR | 2.52% |
| 2009 Q4 | 176.01 Million EUR | 1.04% |
| 2009 FY | 741.33 Million EUR | 14.36% |
| 2009 Q1 | 164.46 Million EUR | 0.0% |
| 2008 FY | 648.23 Million EUR | 9.54% |
| 2007 FY | 591.79 Million EUR | 5.75% |
| 2006 FY | 559.61 Million EUR | 9.23% |
| 2005 FY | 512.31 Million EUR | 15.63% |
| 2004 FY | 443.06 Million EUR | -17.48% |
| 2003 FY | 536.93 Million EUR | 25.66% |
| 2002 FY | 427.28 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -33824.409% |
| Ansell Limited | 624.8 Million USD | 7.745% |
| Ansell Limited | 624.8 Million USD | 7.745% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -405.882% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -426697.971% |
| Psykey, Inc. | 415.97 Thousand USD | -138468.571% |
| ConvaTec Group Plc | 1.2 Billion USD | 52.09% |
| ConvaTec Group Plc | 1.17 Billion USD | 50.935% |
| Encision Inc. | 3.13 Million USD | -18280.707% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -72494.781% |
| LifePoint, Inc. | -71.35 Thousand USD | 807874.882% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 440109.16% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -109692.762% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -95452.682% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -96545.155% |
| SmileDirectClub, Inc. | 275.84 Million USD | -108.961% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 36.006% |
| SheerVision, Inc. | 2.17 Million USD | -26390.63% |
| United Health Products, Inc. | -4857.00 USD | 11867754.931% |
| Vasamed, Inc. | -69.38 Thousand USD | 830808.48% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -215249.899% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1094658.034% |